The US Food and Drug Administration (FDA) has granted marketing approval for the first “digital” pill with a built-in sensor that can track whether patients have taken their medicine.
Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.
Newsletter & e-edition
News, trends and background information as well as the latest issue of CHEManager International